Edition:
United Kingdom

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

678.00GBp
1:16pm BST
Change (% chg)

-12.00 (-1.74%)
Prev Close
690.00
Open
692.00
Day's High
692.00
Day's Low
678.00
Volume
14,307
Avg. Vol
67,940
52-wk High
1,064.38
52-wk Low
575.32

About

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D... (more)

Overall

Beta: -0.01
Market Cap(Mil.): £282.36
Shares Outstanding(Mil.): 3,106.25
Dividend: --
Yield (%): --

Financials

  OXB.L Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.00 -- --
ROI: -24.52 8.91 13.82
ROE: -105.55 10.05 15.24

BRIEF-Oxford Biomedica Says Japanese Approval Of Kymriah

* NOTES AN ANNOUNCEMENT BY NOVARTIS THAT JAPAN'S MINISTRY OF HEALTH, LABOR AND WELFARE (MHLW) HAS APPROVED KYMRIAH Source text for Eikon: Further company coverage:

26 Mar 2019

BRIEF-Oxford BioMedica Notes Longer-Term Analyses From Pivotal Kymriah Trials

* NOTES AN ANNOUNCEMENT BY NOVARTIS ON LONGER-TERM ANALYSES OF BOTH ELIANA AND JULIET PIVOTAL TRIALS

03 Dec 2018

Earnings vs. Estimates